Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Resting State Brain Entropy Alterations in Relapsing Remitting Multiple Sclerosis.
In vitro and in vivo evaluation of a humanized anti-APRIL antibody.
The fraction of varicella zoster virus-specific antibodies among all intrathecally-produced antibodies discriminates between patients with varicella zoster virus reactivation and multiple sclerosis.
Identifying and treating pain caused by MS.
A Potent and Selective S1P(1) Antagonist with Efficacy in Experimental Autoimmune Encephalomyelitis.
Neuregulin1-β Decreases IL-1β-Induced Neutrophil Adhesion to Human Brain Microvascular Endothelial Cells.
FTY720 immunosuppression impairs effector T cell peripheral homing without affecting induction, expansion, and memory.
Previous treatment influences fingolimod efficacy in relapsing-remitting multiple sclerosis: results from an observational study.
Impairment of endothelial function in patients with multiple sclerosis.
New methods for multiple sclerosis drug discovery.
Anti-CD20 inhibits T cell-mediated pathology and microgliosis in the rat brain.
Small molecule glutaminase inhibitors block glutamate release from stimulated microglia.
A patient with both narcolepsy and multiple sclerosis in association with Pandemrix vaccination.
FTY720 (fingolimod) is a neuroprotective and disease-modifying agent in cellular and mouse models of Huntington disease.
Neuroinflammatory Imaging Biomarkers: Relevance to Multiple Sclerosis and its Therapy.
Erratum.
Disease mechanisms in MS: A role for sodium channels in regulation of macrophage-mediated pathology in multiple sclerosis lesions.
Optic neuritis in a psoriatic arthritis patient treated by infliximab.
Sequencing analysis of the human glucocorticoid receptor (NR3C1) gene in multiple sclerosis patients.
LOGISMOS-B: Layered Optimal Graph Image Segmentation of Multiple Objects and Surfaces for the Brain.
The Immunomodulatory and Neuroprotective Effects of Mesenchymal Stem Cells (MSCs) in Experimental Autoimmune Encephalomyelitis (EAE): A Model of Multiple Sclerosis (MS).
Incidence of multiple sclerosis in multiple racial and ethnic groups.
Distinguishing Susac's syndrome from multiple sclerosis.
Patient autonomy in multiple sclerosis - Possible goals and assessment strategies.
JC Polyomavirus Infection Is Strongly Controlled by Human Leucocyte Antigen Class II Variants.
Pages
« first
‹ previous
…
226
227
228
229
230
231
232
233
234
…
next ›
last »